Pharmacy supply chain leaders gathered at the popular Angus Glen venue for timely industry updates on the Patented Medicine Prices Review Board (PMPRB) & the pan-Canadian Pharmaceutical Alliance (pCPA).
Update on PMPRB Framework Modernization Initiative
Director Policy & Economic Analysis
Patented Medicine Prices Review Board
A career public servant, Tanya has a strong grasp of pharmaceutical policy, market dynamics and pricing in Canada & internationally. Tanya delivered a summary of the Patented Medicines Regulatory amendments being proposed, and options for implementing these changes and modernizing the PMPRB Excessive Price Guidelines.
Understanding the pCPA
pan-Canadian Pharmaceutical Alliance Office
Imran provided insights into the pCPA Office which represents all 14 public drug plan jurisdictions in Canada. Imran reviewed pCPA’s history and evolution including a status update on both the brand and generic initiatives.
For more information about future sponsorship opportunities for the 2019 Member Forum, contact Allison Chan at email@example.com or (905)265-1706, ext. 223